By contrast, GAL2R exerted an antitumor effect by inducing cell-cycle arrest and apoptotic mechanisms (caspase 3-dependent) [190] and this means that the activation of these mechanisms could exert a beneficial therapeutic action against HNSCC. Here, CASP3 is linked to head and neck squamous cell carcinoma.